New User Fees Set for Foreign Medical Device Manufacturers in China

Chinese medical device market regulator China Food and Drug Administration (CFDA) has published a draft table of user fees for medical device registrants, and is expected to begin enforcing fee requirements in March 2015.

CFDA registration fees will not be insubstantial: Imported Class II device registrants will be charged about $34,000 for initial registration, while foreign Class III device registrants will have to pay about $49,000 for initial registration. Registration renewals every five years for imported devices will cost registrants $6,500 per renewal. User fees will be charged in addition to in-country testing, clinical trials, authorized representation and translation costs.

A translation of the draft fee table below does not include any potential fees for Class I CFDA record filing or CFDA quality system audits.

CFDA Medical User Fees Unit: Chinese Yuan (RMB) Unit: US Dollars (USD)
    Domestic Imported Domestic Imported
Class II Initial Registration 210,900 33,761
Variation Application 42,000 6,723
Renewal (every 5 years) 40,800 6,531
Class III High Risk MD Clinical Trial Approval 43,200 43,200 6,915 6,915
Initial Registration 153,600 308,800 24,588 49,433
Variation Application 50,400 50,400 8,068 8,068
Renewal (every 5 years) 40,800 40,800 6,531 6,531

USD figures are calculated based on 1/30/2015 exchange rate of 1 RMB = 0.16008 USD

 

Source: Emergo Group 

Related Articles

  • Medical Device Supplier Certification: the Rx-360 Approach

    Rx-360, an international pharmaceutical supply chain consortium, which helps its members share best practices to ensure the integrity of the healthcare supply chain, is now gearing for growth in the device space. What lessons can device makers learn?

  • Trends to Watch For in Medical Device Industry

    Access to recently developed materials, new technological deliveries and access to new markets are only a few of the trends that have affected changes in the medical device market and industry.

  • Unannounced Audits

    Critical subcontractors and crucial suppliers will be subject to unannounced audits by notified bodies under the revised European device regulations. Richard DeRisio of TÜV Süd provides more details in this presentation.

  • Supplier Responsibility in Medical Device Recalls

    What is the responsibility of the design owner? What level of accountability does the supplier have? What follow-up actions must a supplier take? A variety of best practices need to be driven forward by both suppliers and OEMs in an…

Leave a Reply

Your email address will not be published. Required fields are marked *

For security, use of Google's reCAPTCHA service is required which is subject to the Google Privacy Policy and Terms of Use.

If you agree to these terms, please click here.